Literature DB >> 3025268

Importance of anticomplement immunofluorescence antibody titration for diagnosing varicella-zoster virus infection in Bell's palsy.

S Shigeta, M Baba, M Ogata, H Nozaki, A Okuaki, S Nakamura.   

Abstract

Anticomplement Immunofluorescence was used for antibody titration against varicella-zoster virus (VZV) in 43 patients with peripheral facial palsy. Nine of 31 patients (29%) with Bell's palsy and eight of 12 patients (75%) with Ramsey-Hunt syndrome had anticomplement immunofluorescence antibody titres of greater than or equal to 1/10. On the other hand, none of 14 patients with herpes simplex virus (HSV) infection and 51 healthy adults showed anticomplement immunofluorescence antibody titres of greater than or equal to 1/10. The anticomplement immunofluorescence antibody titre in two patients with Ramsey-Hunt syndrome increased later and decreased sooner than the indirect immunofluorescence antibody titre, becoming undetectable at 66 and 104 days, respectively, after onset of the disease. There was no cross reaction between anti-VZV and anti-HSV antibodies in the patients who showed a positive antibody rise for VZV. As the acute stage of VZV infection is obscure in the patients with peripheral facial palsy without herpes the screening of anticomplement immunofluorescence antibody to VZV at titres greater than or equal to 1/10 may be useful for the diagnosis of VZV infection in patients with peripheral facial palsy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3025268      PMCID: PMC1140774          DOI: 10.1136/jcp.39.11.1254

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  8 in total

1.  Peripheral facial palsy and herpes zoster infection.

Authors:  I W Mair; L B Flugsrud
Journal:  J Laryngol Otol       Date:  1976-04       Impact factor: 1.469

2.  Acute facial palsy. Some clinical and virological observations.

Authors:  R Berg; M Forsgren; H Schiratzki
Journal:  Acta Otolaryngol       Date:  1976 May-Jun       Impact factor: 1.494

3.  Varicella-Zoster virus in idiopathic facial palsy.

Authors:  H Tomita; W Hayakawa
Journal:  Arch Otolaryngol       Date:  1972-04

4.  The incidence of herpes zoster antibodies in patients with peripheral facial palsy.

Authors:  E Peitersen; A E Caunt
Journal:  J Laryngol Otol       Date:  1970-01       Impact factor: 1.469

5.  Evaluation of the anticomplement immunofluorescence test for detection of antibody to varicella-zoster virus.

Authors:  C M Preissner; S P Steinberg; A A Gershon; T F Smith
Journal:  J Clin Microbiol       Date:  1982-08       Impact factor: 5.948

6.  Peripheral facial palsy and infections- findings and problems.

Authors:  T Mertens; J P Thomas; C Zippel; H J Eggers
Journal:  Med Microbiol Immunol       Date:  1982       Impact factor: 3.402

7.  Anticomplement immunofluorescence for the titration of antibody to varicella-zoster virus.

Authors:  S Shigeta; M Baba; M Ogata; S Iijima; C Murai
Journal:  Microbiol Immunol       Date:  1981       Impact factor: 1.955

8.  Comparison of anticomplement immunofluorescence and fluorescent antibody-to-membrane antigen tests for determination of immunity status to varicella-zoster virus and for serodifferentiation of varicella-zoster and herpes simplex virus infections.

Authors:  D Gallo; N J Schmidt
Journal:  J Clin Microbiol       Date:  1981-11       Impact factor: 5.948

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.